NEW BRUNSWICK, N.J. -- A real-world study of South African health care workers found that two doses of the Johnson & Johnson COVID-19 vaccine offer 85% protection against hospitalization from the ...

Now that public health officials have recommended a pause in the use of Johnson and Johnson’s COVID-19 vaccine, many who have already received one of the shots are wondering what they should do. As of ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The Baltimore factory contracted to make ...

WASHINGTON - On Tuesday, U.S. officials recommended a "pause" on the use of the Johnson & Johnson COVID-19 vaccine in order to investigate U.S. reports of a rare type of blood clot following ...

BALTIMORE - The U.S. Food and Drug Administration announced Friday it will authorize the release of two batches of Johnson & Johnson’s COVID-19 vaccine manufactured at its troubled Baltimore plant.

BALTIMORE - A dosage mix-up at a Baltimore production facility, which ruined about 15 million doses of Johnson & Johnson’s COVID vaccine, has prompted the U.S. Food and Drug Administration to delay ...

Airline and other travel stocks fell Tuesday after U.S. authorities called for a pause in the use of Johnson & Johnson's Covid-19 vaccine due to rare reports of blood clotting. The Food and Drug ...

WASHINGTON (AP) — U.S. health officials say Johnson & Johnson’s COVID-19 vaccine may pose a “small possible risk” of a rare but potentially dangerous neurological reaction. The Centers for Disease ...

The European Medicines Agency (EMA) has announced an extraordinary meeting of its human medicines committee (CHMP) to evaluate the COVID-19 vaccine developed by Janssen, a Johnson & Johnson division.